Is a Drug Diversion Prevention Program Required?
No federal rule uses the words “diversion prevention program”. Several require what a program is made of. This page sets out which rules apply, what they say, and what is left to your state, your accreditor and you.
The short answer
No federal regulation uses the words “diversion prevention program”. Several federal rules do require what a program is made of: effective controls against theft and diversion, accurate records, locked storage with limited access, and reporting of losses. A program is how you show you meet them. Your state, your accreditor or a settlement agreement may go further, and that depends on where you are and who accredits you.
Where the obligations come from
| Source | What it requires | Applies to |
|---|---|---|
| 21 CFR 1301.71(a) | “All applicants and registrants shall provide effective controls and procedures to guard against theft and diversion of controlled substances.” | Every DEA registrant |
| 21 CFR 1301.76 | No employee with access who has a felony conviction relating to controlled substances, or a DEA registration denied, revoked or surrendered for cause. Written notice of theft or significant loss within one business day of discovery, and a DEA Form 106 within 45 days. | Practitioners, including hospitals and pharmacies |
| 21 CFR Part 1304 | Initial and biennial inventories, and “a complete and accurate record” of each substance received or disposed of, kept for at least two years. | Every registrant that must keep records |
| 42 CFR 482.25 | Records of receipt and disposition of all scheduled drugs; Schedule II to V drugs locked in a secure area; only authorized personnel with access; abuses and losses reported to the pharmacy director and, as appropriate, the CEO. | Hospitals in Medicare |
| State pharmacy law | Can add duties for the pharmacist in charge, inventory timing and loss reporting. | Varies by state |
| Accreditation standards | Medication security and management standards, checked on survey. | Varies by accreditor |
The regulation text is quoted from the 2025 annual edition. Accreditation standards are not quoted here; read the current manual from your accreditor.
What “effective controls” means in practice
The rules say what must be achieved, not how. When an inspector, a surveyor or your own board asks how you guard against diversion, the answer is usually a description of a program:
- a named person or committee who owns it;
- written policies for access, counts, waste and discrepancies;
- a schedule for reviewing transactions, and a record that the reviews happened;
- a written process for investigating a concern and reporting a loss;
- training, so that staff know the warning signs and whom to tell.
For best practice rather than law, health systems usually work from the ASHP Guidelines on Preventing Diversion of Controlled Substances (2022), which set out a comprehensive program. They are guidelines, not regulations. The drug diversion prevention program guide maps each part to a how-to.
When a program becomes a written obligation
After an enforcement action, the program can become a term of a settlement. When Massachusetts General Hospital settled with the United States in 2015 after nurses diverted controlled substances, it adopted a corrective action plan that included enhanced diversion monitoring, annual external audits and fingerprint-based access controls on automated dispensing machines (case record). Other settlements are listed on diversion settlements and fines.
What to check for your own facility
- Your state board of pharmacy rules for your setting: hospital, community pharmacy, long-term care or surgery center can each fall under different sections.
- Your accreditor's current medication management standards.
- Any settlement, consent order or corrective action plan your organization has signed.
- Your own policies: once a policy says you will do something, a surveyor will check that you do it.
Sources
- 21 CFR 1301.71, 1301.76, 1304.04, 1304.11 and 1304.21; 42 CFR 482.25. 2025 annual edition.
- Clark J, Fera T, Fortier C, et al. ASHP Guidelines on Preventing Diversion of Controlled Substances. Am J Health Syst Pharm. 2022;79(24):2279-2306.
Read on October 16, 2026. Educational content, not legal advice.
Further reading
Building the program
What a program contains and how to put it in place.
-
10 Components of a Drug Diversion Prevention Program
The ten elements every credible drug diversion prevention program needs — from governance to surveillance to continuous improvement.
-
What Is Drug Diversion in Healthcare? Definition, Examples & Warning Signs
The definition of drug diversion in hospitals and pharmacies, how it happens, who's typically involved, and the warning signs every program should monitor.
-
Drug Diversion Prevention Program
What a hospital drug diversion prevention program needs — oversight, surveillance, waste controls, investigation — with a free scored self-assessment.
-
Policy Templates
Ready-to-adapt diversion prevention, waste witnessing, POM, and camera policies
-
Training Materials
New hire awareness, annual competency, red flag recognition, and waste documentation
Showing it works
Audits and inspections, from the inside and the outside.
-
Surviving a DEA Inspection: Audit Prep for Diversion Prevention Programs
What DEA investigators look for during a controlled substances inspection, and how to keep your diversion prevention program audit-ready.
-
Drug Diversion Audit
How to audit a controlled substance program for diversion: what to test from ordering to waste, how often, and who should do it. Free self-assessment.
-
DEA Audit Readiness
Prepare for a DEA inspection: inventory, Form 222 and CSOS orders, Form 106 loss reports, Form 41 destruction and renewals, with a free self-assessment.
-
Regulatory Guide
DEA requirements, state board obligations, PDMP mandates, and Joint Commission standards
What the assessment checks
The hospital assessment has 8 sections. These are the 7 items it scores under Governance & Program Oversight:
- Designated Diversion Prevention Officer/Coordinator with defined authority
- Interdisciplinary diversion prevention committee meets quarterly (or more frequently)
- Written diversion prevention policy approved by governing board
- Policy addresses all controlled substance categories (II-V) and all departments
- Annual program effectiveness review with documented improvements
- Executive leadership receives regular diversion metrics dashboard
- Non-punitive reporting culture policy documented and communicated
The other sections: Controlled Substance Lifecycle Management (9), Perioperative & Procedural Areas (6), Data Analytics & Surveillance (9), Personnel & Access Controls (8), Physical Security (7), Incident Reporting & Investigation (9), Regulatory Compliance (8). Each item is weighted, the score updates as you answer, and the result exports to PDF or CSV.
Other topics
See how your program measures up
The free self-assessment scores your own controls: 8 sections, 63 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.
Start the free assessment